"Outcome-Based Pricing for New Pharmaceuticals via Rebates."

Elodie Adida (2021)

> Home

Details and statistics

DOI: 10.1287/MNSC.2019.3574

access: closed

type: Journal Article

metadata version: 2021-03-02

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/mansci/Adida21
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/mansci/Adida21
Elodie Adida:
Outcome-Based Pricing for New Pharmaceuticals via Rebates. Manag. Sci. 67(2): 892-913 (2021)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.